Clinical Trial: Misoprostol for Non-Viable Pregnancies

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Misoprostol for the Medical Management of Non-Viable First Trimester Pregnancies

Brief Summary: The purpose of this study is to examine the effectiveness of Misoprostol (Cytotec; GD Searle and Co., Chicago, IL) for the management of non-viable first trimester pregnancies. Specifically, Misoprostol (15-S-15-methyl PGE1) will be compared to a placebo with expectant management in who have documented non-viable gestations. We will examine the following outcome variables: time to resolution, number of patients requiring dilation and curettage, change in hematocrit, cost to the institution, patient satisfaction, and reported side effects.